The economic costs of caring for people with HIV infection and AIDS in England and Wales

PharmacoEconomics

Volumn 9, Issue 4, 1996, Pages 332-340

  Petrou, Stavros ^a,b   Dooley, Mary ^a   Whitaker, Luke ^a   Beck, Eduard ^a   Kupek, Emil ^a   Wadsworth, Jane ^a   Miller, David ^a   Renton, Adrian ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b MEDTAP International   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0029914863     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199609040-00006     Document Type: Article

References (29)

1. Beck EJ, Kennelly J, McKevitt C, et al. Changing use of hospital services and costs at a London AIDS referral centre, 1983-1989. AIDS 1994; 8: 367-77
2. Borleffs JC, Jager JC, Marinus JJC, et al. Hospital costs for patients with HIV infection in a university hospital in the Netherlands. Health Policy 1990; 16: 43-54
3. Debeaupuis J, Tcheriatchoukine J. Report on the cost of hospital treatment for AIDS. Paris: Inspectorate General of Social Affairs, 1987
4. Drummond M, Davies L. Treating AIDS: the economic issues. Health Policy 1988: 10: 1-19
5. Epstein AM, Seage G, Weissman JS, et al. Costs of medical care and out-of-pocket expenditures for persons with AIDS in the Boston Health Study. Inquiry 1995; 32: 211-21
6. Ginestal J. The regional cost of AIDS in Spain. In: Schwefel D, Leidl R, Rovira J, et al., editors. Economic aspects of AIDS and HIV infection. Berlin: Springer-Verlag, 1990: 195-203
7. Gshrey-Duver I, Exner-Freisfeld H, Kook-Walewski A, et al. Medical services and costs of AIDS patients in an out-patient clinic for infectious diseases. Frankfurt University Hospital. In: Schwefel D, Leidl R, Rovira J, et al., editors. Economic aspects of AIDS and HIV infection. Berlin: Springer-Verlag, 1990: 172-87
8. Hanpft R, Reinecke F, Berke F. Comparing in-patient and out-patient costs for HIV, LAS and AIDS: methodology, results and consequences from a study in Germany. In: Schwefel D, Leidl R, Rovira J, et al., editors. Economic aspects of AIDS and HIV infection. Berlin: Springer-Verlag, 1990: 164-72
9. Hatzakis A, Trichopoulis D. Methodological and practical issues in estimating the direct costs of AIDS/HIV: Greece. In: Drummond MF, Davies L, editors. AIDS: the challenge for economic analysis. Birmingham (England): Health Services Management Centre. University of Birmingham, 1990: 75-81
10. Hellinger FJ. The lifetime cost of treating a person with HIV. JAMA 1993; 270 (4): 474-8
11. Hellinger FJ, Fleishman JA, Hsia DC. AIDS treatment costs during the last months of life: evidence from the ACSUS. Health Serv Res 1994; 29 (5): 569-81
12. Johnson AM, Adler MW, Crown JM. The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: cost of care and prevention in an inner London district. BMJ 1986; 293: 489-92
13. Lambert J, Carrin G. Direct and indirect costs of AIDS in Belgium: a preliminary analysis. In: Schwefel D, Leidl R, Rovira J, et al., editors. Economic aspects of AIDS and HIV infection. Berlin: Springer-Verlag, 1990: 151-60
14. Rees M. Methodological and practical issues in estimating the direct costs of AIDS/HIV: England and Wales. In: Drummond MF, Davies L, editors. AIDS: the challenge for economic analysis. Birmingham (England): Health Services Management Centre, University of Birmingham, 1990: 69-75
15. Tolley K, Gyldmark M. The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe. Health Policy 1993; 24: 55-70
16. Tolley K, Maynard A, Robinson D. HIV/AIDS and social care. Institute for Health Studies. University of Hull and Centre for Health Economics, University of York, Discussion Paper 81, 1991
17. Farnham PG. Defining and measuring the costs of the HIV epidemic to business firms. Public Health Rep 1994; 109 (3): 311-8
18. Farnham PG, Gorsky RD. Costs to business for an HIV-infected worker. Inquiry 1994; 31: 76-88
19. Netten A, Beecham J, editors. Costing community care: theory and practice. Aldershot (England): Ashgate, 1993
20. Arno PS. The non profit sector's response to the AIDS epidemic: community-based services in San Francisco. Am J Public Health 1986; 76 (11): 1325-30
21. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ 1990; 301: 1183-8
22. Whitmore-Overton SE, Tillett HE, Evans BG, et al. Improved survival from diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays. AIDS 1993; 7: 415-20
23. Coleman DG, Beck FJ, Peters BS, et al. Changing disease patterns in AIDS [letter]. BMJ 1992: 304: 839
24. Day NE. The incidence and prevalence of AIDS and other severe HIV disease in England and Wales for 1992-1997: projections using the data to the end of June 1992. London: PHLS Communicable Disease Surveillance Centre, 1993
25. Communicable Diseases Branch: AIDS bulletin points. London: Department of Health, 1993 Jun
26. Seitovsky AA, Rice DP. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. Public Health Rep 1987; 102 (1): 5-17
27. Begley CE, Crane MM, Perdue G. Estimating the mortality costs of AIDS: do estimates of earnings differ? Am J Public Health 1990; 80 (10): 1268-70
28. Johannesson M, Jönsson B. Economic evaluation in health care: is there a role for cost-benefit analysis? Health Policy 1991, 17: 1-23
29. Koopmanschap MA, Ineveld BMV. Towards a new approach for estimating indirect costs of disease. Soc Sci Med 1992; 34 (9): 1005-10